ALVR
Income statement / Annual
Last year (2024), AlloVir, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, AlloVir, Inc.'s net income was -$58.77 M.
See AlloVir, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$165,000.00 |
$1.14 M |
| Cost of Revenue |
$0.00
|
$398,000.00
|
$2.57 M
|
$1.12 M
|
$73,000.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$398,000.00
|
-$2.57 M
|
-$1.12 M
|
-$73,000.00
|
$165,000.00
|
$1.14 M
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
| Research and Development Expenses |
$12.34 M
|
$132.67 M
|
$118.87 M
|
$120.74 M
|
$49.66 M
|
$16.25 M
|
$1.70 M
|
| General & Administrative Expenses |
$42.92 M
|
$48.26 M
|
$52.33 M
|
$49.08 M
|
$21.65 M
|
$10.62 M
|
$3.03 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$42.92 M
|
$48.26 M
|
$52.33 M
|
$49.08 M
|
$21.65 M
|
$10.62 M
|
$3.03 M
|
| Other Expenses |
$10.19 M
|
$0.00
|
$351,000.00
|
-$2.45 M
|
$195,000.00
|
$797,000.00
|
$1.11 M
|
| Operating Expenses |
$65.44 M
|
$180.93 M
|
$171.20 M
|
$169.82 M
|
$71.31 M
|
$26.87 M
|
$4.73 M
|
| Cost And Expenses |
$0.00
|
$181.33 M
|
$171.20 M
|
$169.82 M
|
$71.31 M
|
$26.87 M
|
$4.73 M
|
| Interest Income |
$5.49 M
|
$5.73 M
|
$1.88 M
|
$1.32 M
|
$1.33 M
|
$2.07 M
|
$56,000.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$398,000.00
|
$2.57 M
|
$1.12 M
|
$73,000.00
|
$19,000.00
|
$3.60 M
|
| EBITDA |
-$65.44 M |
-$190.15 M |
-$166.41 M |
-$169.84 M |
-$69.71 M |
-$26.68 M |
-$3.60 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
-161.71
|
-3.17
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
-161.82
|
-3.17
|
| Total Other Income/Expenses Net |
$6.67 M
|
-$9.21 M
|
$2.23 M
|
-$1.14 M
|
$1.53 M
|
$2.86 M
|
$1.17 M
|
| Income Before Tax |
-$58.77 M
|
-$190.54 M
|
-$168.98 M
|
-$170.96 M
|
-$69.78 M
|
-$23.84 M
|
-$2.43 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
-144.48
|
-2.14
|
| Income Tax Expense |
$0.00
|
-$126,000.00
|
-$265,000.00
|
$1.01 M
|
-$1.40 M
|
-$2.07 M
|
$1.17 M
|
| Net Income |
-$58.77 M
|
-$190.42 M
|
-$168.71 M
|
-$171.96 M
|
-$68.38 M
|
-$21.77 M
|
-$2.43 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
-131.96
|
-2.14
|
| EPS |
-0.0117 |
-1.83 |
-2.2 |
-2.74 |
-2.54 |
-0.33 |
-0.0655 |
| EPS Diluted |
-0.0117 |
-1.83 |
-2.2 |
-2.74 |
-2.54 |
-0.33 |
-0.0655 |
| Weighted Average Shares Out |
$5.01 B
|
$104.06 M
|
$76.65 M
|
$62.78 M
|
$26.90 M
|
$65.11 M
|
$37.10 M
|
| Weighted Average Shares Out Diluted |
$5.01 B
|
$104.06 M
|
$76.65 M
|
$62.78 M
|
$26.90 M
|
$65.11 M
|
$37.10 M
|
| Link |
|
|
|
|
|
|
|
